{"id": "1366781668082778113", "creation": 1614701117.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "text": "$INO Expects COVID-19 Phase 2 US Trial Data Early Q2 2021\n\nInovio Pharmaceuticals reported it had completed Phase II enrollment for its trial of its #COVID19 #vaccine &amp; expects to report data early Q2\n\n$ARCT $ATRA $VBIV $VXRT #StocksToWatch #Investment\n\nhttps://t.co/NC8EkjM4F5", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#STOCKSTOWATCH", "#INVESTMENT"]}